Latest debt-to-equity ratio
NeuroOne Medical Technologies Debt-to-equity ratio
Direct answer
NeuroOne Medical Technologies's debt-to-equity ratio is 4.65%.
The verified market snapshot reports 4.65%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 11, 2026.
Get free NeuroOne Medical Technologies email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 4.65%
Explore related company data
View NeuroOne Medical Technologies's market capitalizationView NeuroOne Medical Technologies's price-to-book ratioView NeuroOne Medical Technologies's return on equityView NeuroOne Medical Technologies's dividend yieldView NeuroOne Medical Technologies's 52-week price rangeView NeuroOne Medical Technologies's revenue growthView NeuroOne Medical Technologies's profit marginView all NeuroOne Medical Technologies key metricsReturn to NeuroOne Medical Technologies profile